# Lion's Mane (Hericium erinaceus) - Clinical Longevity Review & Consensus Audit > **Consensus Verdict**: Hericium erinaceus (Lion’s Mane) is a premier medicinal mushroom rich in lipophilic hericenones and diterpenoid erinacines that traverse the blood-brain barrier to stimulate endogenous Nerve Growth Factor (NGF) and Brain-Derived Neurotrophic Factor (BDNF). Multiple randomized double-blind clinical trials document statistically significant improvements in Mini-Mental State Examination (MMSE) and cognitive scores in older adults with mild cognitive impairment, accompanied by elevated circulating BDNF (+36%), improved sleep quality, and significant reductions in subjective anxiety and depression. ## 1. Executive Summary & Scores - **Longevity Evidence Score**: **91/100** - **Evidence Quality Tier**: **silver** - **Human Clinical Evidence Strength**: 90/100 - **Primary Longevity Classification**: supplements - **Safety Margin Score**: 95/100 (Higher is safer) - **Time Burden**: ~1 minutes/day - **Estimated Monthly Cost**: inexpensive - **Adherence Friction**: 1/10 (Lower is easier to sustain) --- ## 2. Biological Mechanisms of Action BDNF acts analogously to molecular "fertilizer" or "miracle grow" for the brain. It binds directly and specifically to Tropomyosin receptor kinase B (TrkB) receptors located on the surface of neurons, triggering complex intracellular signaling cascades (including the vital MAPK/ERK and PI3K/Akt pathways)21. These cascades actively promote neuronal survival, enhance axonal arborization, and structurally strengthen the dense synaptic connections that are the fundamental biological requisite for high-level learning and memory retention21. Simultaneously, the synthesis of NGF aggressively supports the maintenance, repair, and regeneration of the myelin sheath, protecting peripheral and central nerves from age-related degradation and demyelination20. By structurally expanding the hippocampal volume and facilitating the brain's visuospatial sketchpad, targeted Lion's Mane protocols physically repair the neural architecture, mitigating cognitive decline, heavily reducing neuro-inflammatory markers, and demonstrating marked anxiolytic and mood-stabilizing effects in clinical populations21. --- ## 3. Canonical Longevity Vector Impacts (The 8 Longevity Pillars) - **Heart Health & Endothelial Function**: **60/100** [Rank #95 of 133 in Heart] - Effect: Moderate (Mild anti-platelet aggregation and triglyceride reduction) - Mechanism: Inhibits excessive platelet aggregation and reduces serum triglyceride accumulation in preclinical and human models. - **Brain Longevity & Neuroprotection**: **95/100** [Rank #3 of 141 in Brain] - Effect: Very High (+22.5% HDS-R Score in MCI RCT, +36% Serum BDNF in Clinical Trials) - Mechanism: Contains lipophilic hericenones and diterpenoid erinacines that cross the blood-brain barrier to trigger endogenous Nerve Growth Factor (NGF) and Brain-Derived Neurotrophic Factor (BDNF) transcription. - **Metabolic Flexibility & Glycemic Control**: **65/100** [Rank #68 of 129 in Metabolic] - Effect: Moderate (Improves lipid metabolism and pro-BDNF signaling in overweight adults) - Mechanism: Improves peripheral neurotrophin signaling and enhances metabolic insulin sensitivity in adipose tissue. - **Cancer Defense & DNA Repair**: **58/100** [Rank #35 of 120 in Cancer Defense] - Effect: Moderate (Immune-modulating beta-glucans enhancing macrophage phagocytosis) - Mechanism: Fruiting body beta-glucans bind dectin-1 receptors on innate immune leukocytes, stimulating systemic anti-tumor surveillance. - **Endocrine & Anabolic Balance**: **0/100** [Rank #81 of 120 in Endocrine] - Effect: Neutral - Mechanism: Neutral direct androgen receptor or steroidogenic action. - **Chronic Inflammation Reduction**: **78/100** [Rank #41 of 126 in Inflammation] - Effect: Moderate-High (-32% CES-D Depression & -38% Anxiety Scores in Human RCT) - Mechanism: Dampens neuro-inflammatory microglial signaling cascades and enhances central vagal parasympathetic neurotransmission. - **Bone Density & Connective Matrix**: **0/100** [Rank #111 of 142 in Bone Matrix] - Effect: Neutral - Mechanism: Neutral direct bone mineral deposition. - **Cellular Longevity & Autophagy**: **72/100** [Rank #101 of 131 in Cellular] - Effect: Moderate (Protects against amyloid-beta proteotoxicity and promotes neurite branching) - Mechanism: Induces neuroplastic sprouting and enhances cellular proteostatic resilience against neurotoxic protein oligomers. --- ## 4. Practical Protocol & Administration Guidelines - **Standard Clinical Dosage**: 1000-2000mg (Dual Extract) - **Recommended Timing**: Morning or midday with meal - **Administration Type**: supplement - **Recommended Biomarkers to Monitor**: focus, memory, mood, bone_density, heart_health, testosterone --- ## 5. Safety, Contraindications & Drug Interactions - **Contraindications**: Known severe allergy or hypersensitivity to mushrooms or fungal extracts, Concurrent systemic immunosuppressive therapy post-organ transplantation without specialist guidance - **Safety Profile**: low_risk - Mild loose stools or abdominal fullness during initial days; Rare cutaneous itch or mild skin redness in allergic individuals --- ## 6. Peer-Reviewed Human Clinical Trials & Key PMIDs 1. **Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake** [PMID: 20834180] - Link: https://pubmed.ncbi.nlm.nih.gov/20834180/ 2. **Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial** [PMID: 18844289] - Link: https://pubmed.ncbi.nlm.nih.gov/18844289/ 3. **Improvement of cognitive functions by oral intake of Hericium erinaceus** [PMID: 31413233] - Link: https://pubmed.ncbi.nlm.nih.gov/31413233/ 4. **Hericium erinaceus Improves Mood and Sleep Disorders in Patients Affected by Overweight or Obesity** [PMID: 31214224] - Link: https://pubmed.ncbi.nlm.nih.gov/31214224/ --- ## 7. Canonical Citation & Web Verification - **Official Web Review**: [Lion's Mane (Hericium erinaceus) on LongevityReviews](https://longevityreviews.org/modalities/lions_mane) - **Last Evidence Calibration**: 2026-09-09 - **Review Policy**: 0% sponsored placements, independent peer-reviewed consensus.